Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

ER+ and AR+ Breast Cancer 1

Interventions

ostarine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × ER+ and AR+ Breast Cancer × ostarine × Clear all
NCT02746328 2024-02-26

Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass

GTx

Phase 2 Withdrawn
Breast

ER+ and AR+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡